Physician profile
Kenneth Chen
NPI 1881794881
$1,115.61
in general payments reported to CMS, 2019-2025
11 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $122 · 2021: $141 · 2022: $70.98 · 2023: $233 · 2024: $161 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $342.91 | 2020-2025 | Doc Band |
| Glaxosmithkline, LLC. | $225.70 | 2019-2024 | Rotarix, Pediarix, Bexsero |
| Ironshore Pharmaceuticals INC. | $154.11 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $148.89 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Phadia US INC. | $60.27 | 2019 | |
| Sobi, INC | $53.65 | 2020-2023 | |
| Ars Pharmaceuticals Operations, INC. | $50.14 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $23.80 | 2025 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $21.90 | 2021 | |
| Shire North American Group INC | $18.40 | 2019 | |
| Seqirus USA INC | $15.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.